Pizarra, Mercedes D.

HRN: 25-35-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/18/2026
01/24/2026
IV
2.25g
Q6h
Complicated UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines